Search
for
Sort by
Research 331–360 of 1000+
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Alopecia Areata: Current Treatments and New Directions
- Pathomechanisms of immune-mediated alopecia
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Alopecia areata: medical treatments
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Dermatologic Adverse Events from Cancer Treatments
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Beyond the follicle
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes